Cited by 2,149Multiple Sclerosis Research StudiesT-cell and B-cell ImmunologyPsoriasis: Treatment and Pathogenesis

The DOI matches its Crossref record; 362 of the 362 references it cites were found in a registry or an index.

IMMUNOLOGY OF MULTIPLE SCLEROSIS

Sospedra, Mireia, Martin, Roland·2005·Annual Review of Immunology

DOI 10.1146/annurev.immunol.23.021704.115707

Open this paper in CoChat — free account

Abstract

Multiple sclerosis (MS) develops in young adults with a complex predisposing genetic trait and probably requires an inciting environmental insult such as a viral infection to trigger the disease. The activation of CD4+ autoreactive T cells and their differentiation into a Th1 phenotype are a crucial events in the initial steps, and these cells are probably also important players in the long-term evolution of the disease. Damage of the target tissue, the central nervous system, is, however, most likely mediated by other components of the immune system, such as antibodies, complement, CD8+ T cells, and factors produced by innate immune cells. Perturbations in immunomodulatory networks that include Th2 cells, regulatory CD4+ T cells, NK cells, and others may in part be responsible for the relapsing-remitting or chronic progressive nature of the disease. However, an important paradigmatic shift in the study of MS has occurred in the past decade. It is now clear that MS is not just a disease of the immune system, but that factors contributed by the central nervous system are equally important and must be considered in the future.

Integrity signals

Registry

Crossref · 10.1146/annurev.immunol.23.021704.115707

Cites

362 of 362 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Control of Regulatory T Cell Development by the Transcription Factor Foxp3
Hori, S., Nomura, T., & Sakaguchi, S. (2003) · Science · doi:10.1126/science.1079490 · Cited by 8,187
Axonal transection in the lesions of multiple sclerosis
Trapp, B. D., Peterson, J., Ransohoff, R. M., Rudick, R., Mörk, S., & Bö, L. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801293380502 · Cited by 4,029
Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain
Cua, D. J., Sherlock, J., Chen, Y., Murphy, C. A., Joyce, B., Seymour, B., Lucian, L., To, W., Kwan, S., Churakova, T., et al. (2003) · Nature · doi:10.1038/nature01355 · Cited by 2,906
Toll Pathway-Dependent Blockade of CD4 + CD25 + T Cell-Mediated Suppression by Dendritic Cells
Pasare, C., & Medzhitov, R. M. (2003) · Science · doi:10.1126/science.1078231 · Cited by 2,000
Use of a cDNA microarray to analyse gene expression patterns in human cancer
DeRisi, J. L., Penland, L., Brown, P. O., Bittner, M. L., Meltzer, P. S., Ray, M., Chen, Y.-W., Su, Y. A., & Trent, J. M. (1996) · Nature Genetics · doi:10.1038/ng1296-457 · Cited by 1,952
Counting Antigen-Specific CD8 T Cells: A Reevaluation of Bystander Activation during Viral Infection
Murali‐Krishna, K., Altman, J. D., Suresh, M., Sourdive, D. J. D., Zajac, A. J., Miller, J. D., Slansky, J. E., & Ahmed, R. (1998) · Immunity · doi:10.1016/s1074-7613(00)80470-7 · Cited by 1,918
Loss of Functional Suppression by CD4+CD25+ Regulatory T Cells in Patients with Multiple Sclerosis
Viglietta, V., Baecher‐Allan, C., Weiner, H. L., & Hafler, D. A. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031579 · Cited by 1,858
Dendritic Cells Induce Peripheral T Cell Unresponsiveness under Steady State Conditions in Vivo
Hawiger, D., Inaba, K., Dorsett, Y., Guo, M., Mahnke, K., Rivera, M. N., Ravetch, J. V., Steinman, R. M., & Nussenzweig, M. C. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.6.769 · Cited by 1,848
Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease
Monney, L., Sabatos, C. A., Gaglia, J. L., Ryu, A., Waldner, H., Chernova, T., Manning, S., Greenfield, E. A., Coyle, A. J., Sobel, R. A., et al. (2002) · Nature · doi:10.1038/415536a · Cited by 1,683
Copolymer 1 reduces relapse rate and improves disability in relapsing‐remitting multiple sclerosis
Johnson, K., Brooks, B., Cohen, J. A., Ford, C., Goldstein, J., Lisak, R., Myers, L., Panitch, H., Rose, J., Schiffer, R., et al. (1995) · Neurology · doi:10.1212/wnl.45.7.1268 · Cited by 1,667

Show all 362 references

Research works printed but not linked: 12

McFarland HF, 1999, Am. J. Neuroradiol., 20, 1777
10.1172/JCI200421357 · DOI
Charcot J, 1868, Gaz. Hopitaux, 41, 554
Remlinger J, 1905, Ann. Inst. Pasteur, 19, 625
Berger T, 1997, Lab. Invest., 76, 355
10.1097/00019052-200306000-00004 · DOI
Sharief MK, 1991, Brain, 114, 181
Bornstein MB, 1959, Trans. Am. Neurol. Assoc., 84, 165
10.1002/1531-8249(200006)47:6<694::AID-ANA2>3.0.CO;2-W · DOI
Linington C, 1988, Am. J. Pathol., 130, 443
Benczur M, 1980, Clin. Exp. Immunol., 39, 657
10.1002/1531-8249(199909)46:3<296::AID-ANA4>3.0.CO;2-# · DOI

Sorted by citations

Items 801–900 of 1,006

NIR-emitting benzothiazolium cyanines with an enhanced stokes shift for mitochondria imaging in live cells
Abeywickrama, C. S., Baumann, H. J., Alexander, N. E., Shriver, L. P., Konopka, M., & Pang, Y. (2018) · Organic & Biomolecular Chemistry · doi:10.1039/c8ob00327k · Cited by 39
A novel neurotherapeutic for multiple sclerosis, ischemic injury, methamphetamine addiction, and traumatic brain injury
Vandenbark, A. A., Meza‐Romero, R., Benedek, G., & Offner, H. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1393-0 · Cited by 39
Disability in multiple sclerosis is associated with age and inflammatory, metabolic and oxidative/nitrosative stress biomarkers: results of multivariate and machine learning procedures
Flauzino, T., Simão, A. N. C., Pereira, W. L. D. C. J., Alfieri, D. F., Oliveira, S. R., Kallaur, A. P., Lozovoy, M. A. B., Kaimen-Maciel, D. R., Maes, M. H. J., & Reiche, E. M. V. (2019) · Metabolic Brain Disease · doi:10.1007/s11011-019-00456-7 · Cited by 40
Ameliorating potential of curcumin and its analogue in central nervous system disorders and related conditions: A review of molecular pathways
Joshi, P., Bisht, A., Joshi, S., Semwal, D. K., Nema, N. K., Dwivedi, J., & Sharma, S. K. (2022) · Phytotherapy Research · doi:10.1002/ptr.7522 · Cited by 39
HLA-DQ8 (DQB1*0302)-Restricted Th17 Cells Exacerbate Experimental Autoimmune Encephalomyelitis in HLA-DR3-Transgenic Mice
Mangalam, A. K., Luckey, D. H., Basal, E., Jackson, M., Smart, M. K., Rodriguez, M., & David, C. S. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803918 · Cited by 39
Inhibition of Transmethylation Down-Regulates CD4 T Cell Activation and Curtails Development of Autoimmunity in a Model System
Lawson, B. R., Manenkova, Y., Ahamed, J., Chen, X., Zou, J.-P., Baccalà, R., Theofilopoulos, A. N., & Yuan, C. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.8.5366 · Cited by 39
Absence of IFN-γ Increases Brain Pathology in Experimental Autoimmune Encephalomyelitis–Susceptible DRB1*0301.DQ8 HLA Transgenic Mice through Secretion of Proinflammatory Cytokine IL-17 and Induction of Pathogenic Monocytes/Microglia into the Central Nervous System
Mangalam, A. K., Luo, N., Luckey, D. H., Papke, L. M., Hubbard, A., Wussow, A., Smart, M. K., Giri, S., Rodriguez, M., & David, C. S. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1302008 · Cited by 39
Multiple Sclerosis and the Blood-Central Nervous System Barrier
Palmer, A. M. (2013) · Cardiovascular Psychiatry and Neurology · doi:10.1155/2013/530356 · Cited by 40
Analysis of HLA DR2&DQ6 (DRB1*1501, DQA1*0102, DQB1*0602) Haplotypes in Iranian Patients with Multiple Sclerosis
Ghabaee, M., Bayati, A., Saroukolaei, S. A., Sahraian, M. A., Sanati, M. H., Karimi, P., Houshmand, M., Sadeghian, H., & Chelavi, L. H. (2008) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-008-9302-1 · Cited by 39
Regulation of Th1/Th17 cytokines and IDO gene expression by inhibition of calpain in PBMCs from MS patients
Smith, A. W., Doonan, B. P., Tyor, W. R., Abou-Fayssal, N., Haque, A., & Banik, N. L. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.09.030 · Cited by 39
Low DPP4 expression and activity in multiple sclerosis
Tejera‐Alhambra, M., Casrouge, A., de Andrés, C., Ramos‐Medina, R., Alonso, B., Vega, J., Albert, M. L., & Sánchez‐Ramón, S. (2013) · Clinical Immunology · doi:10.1016/j.clim.2013.11.011 · Cited by 40
Environmental factors in early childhood are associated with multiple sclerosis: a case-control study
Conradi, S., Malzahn, U., Schröter, F., Paul, F., Quill, S., Spruth, E. J., Harms, L., Bergh, F. T., Ditzenbach, A., Georgi, T., et al. (2011) · BMC Neurology · doi:10.1186/1471-2377-11-123 · Cited by 39
Microglia Play a Major Role in Direct Viral-Induced Demyelination
Chatterjee, D., Biswas, K., Nag, S., Ramachandra, S. G., & Sarma, J. D. (2013) · Clinical and Developmental Immunology · doi:10.1155/2013/510396 · Cited by 39
Retracted
Myelin deficiencies visualized in vivo: Visually evoked potentials and T2‐weighted magnetic resonance images of shiverer mutant and wild‐type mice
Martin, M., Hiltner, T. D., Wood, J. C., Fraser, S. E., Jacobs, R. E., & Readhead, C. W. (2006) · Journal of Neuroscience Research · doi:10.1002/jnr.21086 · Cited by 39
The translocator protein ligand XBD173 improves clinical symptoms and neuropathological markers in the SJL/J mouse model of multiple sclerosis
Leva, G., Klein, C., Benyounes, J., Hallé, F., Bihel, F. J. ‐., Collongues, N., Seze, J. D., Mensah‐Nyagan, A. G., & Patte‐Mensah, C. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.09.007 · Cited by 42
Vaccines for Multiple Sclerosis
Correale, J. D., Farez, M., & Gilmore, W. (2008) · CNS Drugs · doi:10.2165/00023210-200822030-00001 · Cited by 39
Cytotoxic T lymphocytes and autoimmunity
Blanco, P., Viallard, J., Pellegrin, J., & Moreau, J. (2005) · Current Opinion in Rheumatology · doi:10.1097/01.bor.0000179942.27777.f8 · Cited by 39
Social stress alters the severity and onset of the chronic phase of Theiler's virus infection
Johnson, R. R., Prentice, T. W., Bridegam, P., Young, C. R., Steelman, A. J., Welsh, T. H., Welsh, C. J., & Meagher, M. W. (2006) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.02.014 · Cited by 39
The GPR17 receptor-A promising goal for therapy and a potential marker of the neurodegenerative process in multiple sclerosis
Dziedzic, A., Miller, E., Saluk-Bijak, J., & Bijak, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21051852 · Cited by 38
Epistasis and immunity: the role of genetic interactions in autoimmune diseases
Rose, A. M., & Bell, L. C. K. (2012) · Immunology · doi:10.1111/j.1365-2567.2012.03623.x · Cited by 40
Impact of a switch to fingolimod versus staying on glatiramer acetate or beta interferons on patient- and physician-reported outcomes in relapsing multiple sclerosis: post hocanalyses of the EPOC trial
Calkwood, J., Cree, B., Crayton, H. J., Kantor, D., Steingo, B., Barbato, L., Hashmonay, R., Agashivala, N., McCague, K., Tenenbaum, N., et al. (2014) · BMC Neurology · doi:10.1186/s12883-014-0220-1 · Cited by 38
(5R)-5-Hydroxytriptolide (LLDT-8), a novel triptolide derivative, prevents experimental autoimmune encephalomyelitis via inhibiting T cell activation
Fu, Y., Zhu, Y., Ni, J., Zhong, X., Tang, W., Zhou, R., Zhou, Y., Dong, J.-R., He, P., Wan, H., et al. (2006) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.03.011 · Cited by 38
CSF levels of soluble HLA-G and Fas molecules are inversely associated to MRI evidence of disease activity in patients with relapsing—remitting multiple sclerosis
Fainardi, E., Rizzo, R., Melchiorri, L., Stignani, M., Castellazzi, M., Tamborino, C., Paolino, E., Tola, M. R., Granieri, E., & Baricordi, O. R. (2008) · Multiple Sclerosis Journal · doi:10.1177/1352458507085137 · Cited by 38
Anti-inflammatory effects of oroxylin A on RAW 264.7 mouse macrophages induced with polyinosinic-polycytidylic acid
Lee, J. Y., & Park, W. (2016) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2016.3320 · Cited by 39
Impact of Exercise on Innate Immunity in Multiple Sclerosis Progression and Symptomatology
Barry, A., Cronin, O., Ryan, A., Sweeney, B. J., Yap, S. M., O’Toole, O., Allen, A. P., Clarke, G. A., O’Halloran, K. D., & Downer, E. J. (2016) · Frontiers in Physiology · doi:10.3389/fphys.2016.00194 · Cited by 42
Novel feedback loop between M2 macrophages/microglia and regulatory B cells in estrogen-protected EAE mice
Benedek, G., Zhang, J., Nguyen, H., Kent, G., Seifert, H. A., Vandenbark, A. A., & Offner, H. (2017) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2016.12.018 · Cited by 38
Modulating inflammation and neuroprotection in multiple sclerosis
Yong, H. Y. F., Chartier, G., & Quandt, J. A. (2017) · Journal of Neuroscience Research · doi:10.1002/jnr.24090 · Cited by 39
Human Leukocyte Antigen (HLA)-DRB1*15:01 and HLA-DRB5*01:01 Present Complementary Peptide Repertoires
Scholz, E., Marcilla, M., Daura, X., Arribas-Layton, D., James, E. A., & Álvarez, I. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00984 · Cited by 38
The role of immune regulatory molecules in multiple sclerosis
Afshar, B., Khalifehzadeh-Esfahani, Z., Seyfizadeh, N., Danbaran, G. R., Hemmatzadeh, M., & Mohammadi, H. (2019) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2019.577061 · Cited by 38
How Does Protein Zero Assemble Compact Myelin?
Raasakka, A., & Kursula, P. (2020) · Cells · doi:10.3390/cells9081832 · Cited by 41
Encephalitogenic and Regulatory CD8 T Cells in Multiple Sclerosis and Its Animal Models
Mockus, T. E., Munie, A. N., Atkinson, J., & Segal, B. M. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.2000797 · Cited by 38
Targeting epidermal fatty acid binding protein for treatment of experimental autoimmune encephalomyelitis
Rao, E., Singh, P., Li, Y., Zhang, Y., Chi, Y., Suttles, J., & Li, B. (2015) · BMC Immunology · doi:10.1186/s12865-015-0091-2 · Cited by 38
Statins’ immunomodulatory potential against Th17 cell-mediated autoimmune response
Zhang, X., & Markovic‐Plese, S. (2008) · Immunologic Research · doi:10.1007/s12026-008-8019-z · Cited by 38
Endogenous remyelination is induced by transplant rejection in a viral model of multiple sclerosis
Hatch, M. N., Schaumburg, C. S., Lane, T. E., & Keirstead, H. S. (2009) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2009.05.002 · Cited by 38
Antigen-Specific Therapies in Multiple Sclerosis: Going Beyond Proteins and Peptides
da Fontoura, P. P., Garren, H., & Steinman, L. (2005) · International Reviews of Immunology · doi:10.1080/08830180500379655 · Cited by 38
Urinary tract infections in multiple sclerosis: under-diagnosed and under-treated? A clinical audit at a large University Hospital.
Mahadeva, A., Tănăsescu, R., & Gran, B. (2014) · Europe PMC (PubMed Central) · Cited by 37
Dysregulated RNA-Induced Silencing Complex (RISC) Assembly within CNS Corresponds with Abnormal miRNA Expression during Autoimmune Demyelination
Lewkowicz, P., Ćwiklińska, H., Mycko, M. P., Cichalewska, M., Domowicz, M., Lewkowicz, N., Jurewicz, A., & Selmaj, K. W. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.4794-14.2015 · Cited by 37
Cannabinoids and experimental models of multiple sclerosis
Kubajewska, I., & Constantinescu, C. S. (2009) · Immunobiology · doi:10.1016/j.imbio.2009.08.004 · Cited by 37
An epitope from Acanthamoeba castellanii that cross-react with proteolipid protein 139-151-reactive T cells induces autoimmune encephalomyelitis in SJL mice
Massilamany, C., Steffen, D. J., & Reddy, J. (2009) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2009.11.006 · Cited by 37
Isolation and Th17 Differentiation of Naïve CD4 T Lymphocytes
Bedoya, S. K., Wilson, T. D., Collins, E. L., Lau, K., & Larkin, J. (2013) · Journal of Visualized Experiments · doi:10.3791/50765 · Cited by 37
DNA-based vaccines for multiple sclerosis: Current status and future directions
Fissolo, N., Montalbán, X., & Comabella, M. (2010) · Clinical Immunology · doi:10.1016/j.clim.2010.11.011 · Cited by 38
IFN-β and multiple sclerosis: Cross-talking of immune cells and integration of immunoregulatory networks
Severa, M., Rizzo, F., Giacomini, E., Salvetti, M., & Coccia, E. M. (2014) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2014.11.005 · Cited by 38
Live Imaging of Immune Responses in Experimental Models of Multiple Sclerosis
Rossi, B., & Constantin, G. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00506 · Cited by 39
Nogo-A Antibodies for Progressive Multiple Sclerosis
Ineichen, B. V., Plattner, P. S., Good, N., Martinꝉ, R., Linnebank, M., & Schwab, M. E. (2017) · CNS Drugs · doi:10.1007/s40263-017-0407-2 · Cited by 37
Self-citation
Autophagy and Autophagy-Related Proteins in CNS Autoimmunity
Keller, C. W., & Lünemann, J. D. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00165 · Cited by 38
Transplantation of glial-committed progenitor cells into a viral model of multiple sclerosis induces remyelination in the absence of an attenuated inflammatory response
Hardison, J. L., Nistor, G., Gonzalez, R., Keirstead, H. S., & Lane, T. E. (2005) · Experimental Neurology · doi:10.1016/j.expneurol.2005.10.016 · Cited by 37
Soluble HLA-G molecules are released as HLA-G5 and not as soluble HLA-G1 isoforms in CSF of patients with relapsing–remitting Multiple Sclerosis
Fainardi, E., Rizzo, R., Melchiorri, L., Stignani, M., Castellazzi, M., Caniatti, L. M., Baldi, E., Tola, M. R., Granieri, E., & Baricordi, O. R. (2007) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2007.10.002 · Cited by 37
Interferon-beta modifies the peripheral blood cell cytokine secretion in patients with multiple sclerosis
Mirandola, S. R., Longo, D. E. M. H., Farias, A. S., de Oliveira, E. C., Brandão, C. O., Ruocco, H. H., Damasceno, B. P., & dos Santos, L. M. B. (2009) · International Immunopharmacology · doi:10.1016/j.intimp.2009.03.004 · Cited by 37
Current and Future Therapies Targeting the Immune System in Multiple Sclerosis
Loleit, V., Biberacher, V., & Hemmer, B. (2014) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201015666140617104332 · Cited by 37
Control of IL-17 receptor signaling and tissue inflammation by the p38α–MKP-1 signaling axis in a mouse model of multiple sclerosis
Huang, G., Wang, Y., Vogel, P., & Chi, H. (2015) · Science Signaling · doi:10.1126/scisignal.aaa2147 · Cited by 37
Comparative Neuroregenerative Effects of C-Phycocyanin and IFN-Beta in a Model of Multiple Sclerosis in Mice
Pentón-Rol, G., Lagumersindez-Denis, N., Muzio, L., Bergami, A., Furlan, R., Fernández-Massó, J. R., Nazabal-Galvez, M., Llópiz-Arzuaga, A., Herrera-Rolo, T., Veliz-Rodriguez, T., et al. (2016) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-015-9642-9 · Cited by 36
Epstein-Barr Virus and Multiple Sclerosis
Lünemann, J. D., & Münz, C. (2007) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-007-0038-y · Cited by 36
Antigen-specific tolerization approaches in multiple sclerosis
Lutterotti, A., & Martinꝉ, R. (2013) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2014.844788 · Cited by 36
Self-citation
A Comparative Perspective on Wnt/β-Catenin Signalling in Cell Fate Determination
Garcin, C. L., & Habib, S. J. (2017) · Results and problems in cell differentiation · doi:10.1007/978-3-319-53150-2_15 · Cited by 40
Sphingosine-1 Phosphate and Central Nervous System
Martinꝉ, R., & Sospedra, M. (2014) · Current topics in microbiology and immunology · doi:10.1007/978-3-319-05879-5_7 · Cited by 37
Self-citation
Function of innate lymphoid cells in the immune-related disorders
Džopalić, T., Nedeljković, B. B., & Jurišić, V. (2019) · Human Cell · doi:10.1007/s13577-019-00257-1 · Cited by 37
Deubiquitinating enzymes (DUBs): DoUBle-edged swords in CNS autoimmunity
Ruan, J., Schlüter, D., & Wang, X. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01783-8 · Cited by 38
T-Cell Specificity Influences Disease Heterogeneity in Multiple Sclerosis
Cruciani, C., Puthenparampil, M., Ojer, P. T., Jelčić, I., Docampo, M. J., Planas, R., Manogaran, P., Opfer, R., Wicki, C. A., Reindl, M., et al. (2021) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000001075 · Cited by 39
Self-citation
The application of soft systems thinking in SDG interaction studies: a comparison between SDG interactions at national and subnational levels in Colombia
Hernández-Orozco, E., Alva, I. L., Cárdenas-Vélez, M., Purkey, D., Nilsson, M., & Martin, P. (2021) · Environment Development and Sustainability · doi:10.1007/s10668-021-01808-z · Cited by 36
HLA-DMA Polymorphisms Differentially Affect MHC Class II Peptide Loading
Álvaro‐Benito, M., Wieczorek, M., Sticht, J., Kipar, C., & Freund, C. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1401389 · Cited by 36
Translocator protein 18 kDa (TSPO) expression in multiple sclerosis patients
Harberts, E., Datta, D., Chen, S., Wohler, J. E., Oh, U., & Jacobson, S. (2013) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-012-9397-5 · Cited by 36
Plasmacytoid dendritic cells in multiple sclerosis: Chemokine and chemokine receptor modulation by interferon-beta
Aung, L. L., Fitzgerald-Bocarsly, P. A., Dhib-Jalbut, S. S., & Balashov, K. E. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.06.008 · Cited by 38
Th1 Polarization of CD4+ T Cells by Toll-Like Receptor 3-Activated Human Microglia
Jack, C. S., Arbour, N., Blain, M., Meier, U., Prat, A., & Antel, J. P. (2007) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181492a7 · Cited by 36
Interferon-beta therapy in multiple sclerosis: the short-term and long-term effects on the patients’ individual gene expression in peripheral blood
Hecker, M., Hartmann, C., Kandulski, O., Paap, B. K., Koczan, D., Thiesen, H., & Zettl, U. K. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8463-1 · Cited by 36
Monoclonal antibody therapy in multiple sclerosis
da Fontoura, P. P. (2010) · mAbs · doi:10.4161/mabs.2.6.13270 · Cited by 36
B-Cell Depletion Attenuates White and Gray Matter Pathology in Marmoset Experimental Autoimmune Encephalomyelitis
Kap, Y. S., Bauer, J., van Driel, N., Bleeker, W. K., Parren, P. W. H. I., Kooi, E., Geurts, J. J. G., Laman, J. D., Craigen, J. L., Blezer, E. L. A., et al. (2011) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e318234d421 · Cited by 36
Relevance of Molecular Mimicry in the Mediation of Infectious Myocarditis
Massilamany, C., Huber, S. A., Cunningham, M. W., & Reddy, J. (2013) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-013-9519-3 · Cited by 36
Cerebrospinal fluid concentration of Galectin-9 is increased in secondary progressive multiple sclerosis
Burman, J., & Svenningsson, A. (2016) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2016.01.008 · Cited by 36
Blockade of CD47 ameliorates autoimmune inflammation in CNS by suppressing IL-1-triggered infiltration of pathogenic Th17 cells
Gao, Q., Zhang, Y., Han, C., Hu, X., Zhang, H., Xu, X., Tian, J., Liu, Y., Ding, Y., Liu, J., et al. (2016) · Journal of Autoimmunity · doi:10.1016/j.jaut.2016.03.002 · Cited by 36
Altered T cell phenotypes associated with clinical relapse of multiple sclerosis patients receiving fingolimod therapy
Fujii, C., Kondo, T., Ochi, H., Okada, Y., Hashi, Y., Adachi, T., Shin‐Ya, M., Matsumoto, S., Takahashi, R., Nakagawa, M., et al. (2016) · Scientific Reports · doi:10.1038/srep35314 · Cited by 36
The Association Between Vitamin D and Multiple Sclerosis Risk: 1,25(OH)2D3 Induces Super-Enhancers Bound by VDR
Lu, M., McComish, B. J., Burdon, K. P., Taylor, B. V., & Körner, H. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00488 · Cited by 37
Impairment of Mitochondrial Redox Status in Peripheral Lymphocytes of Multiple Sclerosis Patients
Gonzalo‐Benito, H., Nogueras, L., Gil-Sánchez, A., Hervás, J. V., Valcheva, P., González‐Mingot, C., Martin‐Garí, M., Canudes, M., Peralta, S., Solana, M. J., et al. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00938 · Cited by 37
Splice variation in the cytoplasmic domains of myelin oligodendrocyte glycoprotein affects its cellular localisation and transport1
Boyle, L. H., Traherne, J. A., Plotnek, G., Ward, R. D., & Trowsdale, J. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04687.x · Cited by 36
Methylprednisolone inhibits IFN-γ and IL-17 expression and production by cells infiltrating central nervous system in experimental autoimmune encephalomyelitis
Miljković, Ž., Momčilović, M., Miljković, D., & Mostarica-Stojković, M. (2009) · Journal of Neuroinflammation · doi:10.1186/1742-2094-6-37 · Cited by 35
Immunomodulatory effects and improved prognosis of experimental autoimmune encephalomyelitis after O-tetradecanoyl-genistein treatment
de Castro, S. B. R., Júnior, C. D. O. R., Alves, C. C. D. S., Dias, A. T., Alves, L. L., Mazzoccoli, L., Mesquita, F. P., de Figueiredo, N. S. V., Juliano, M. A., Castañon, M. C. M. N., et al. (2012) · International Immunopharmacology · doi:10.1016/j.intimp.2011.12.025 · Cited by 35
IL-23 Plasma level measurement in relapsing remitting multiple sclerosis (RRMS) patients compared to healthy subjects
Shajarian, M., Alsahebfosoul, F., Etemadifar, M., Sedaghat, N., Shahbazi, M., Firouzabadi, F. P., & Dezashibi, H. M. (2014) · Immunological Investigations · doi:10.3109/08820139.2014.930477 · Cited by 37
Interferon regulatory factor (IRF) 3 is critical for the development of experimental autoimmune encephalomyelitis
Fitzgerald, D. C., O’Brien, K., Young, A., Fonseca-Kelly, Z., Rostami, A. M., & Gran, B. (2014) · Journal of Neuroinflammation · doi:10.1186/1742-2094-11-130 · Cited by 35
Oral administration of the nitroxide radical TEMPOL exhibits immunomodulatory and therapeutic properties in multiple sclerosis models
Neil‐Sztramko, S., Huh, J., Baronas, V. A., Li, X., McFarland, H. F., Cherukuri, M. K., Mitchell, J. B., & Quandt, J. A. (2017) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2017.02.018 · Cited by 35
A Nanobiosensor Based on Fluorescent DNA-Hosted Silver Nanocluster and HCR Amplification for Detection of MicroRNA Involved in Progression of Multiple Sclerosis
Mansourian, N., Rahaie, M., & Hosseini, M. (2017) · Journal of Fluorescence · doi:10.1007/s10895-017-2105-3 · Cited by 35
TLR7 Signaling Regulates Th17 Cells and Autoimmunity: Novel Potential for Autoimmune Therapy
Ye, J., Wang, Y., Liu, X., Li, L., Opejin, A., Hsueh, E. C., Luo, H., Wang, T., Hawiger, D., & Peng, G. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1601890 · Cited by 36
Detailed Characterization of T Cell Receptor Repertoires in Multiple Sclerosis Brain Lesions
Planas, R., Metz, I., Martinꝉ, R., & Sospedra, M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00509 · Cited by 35
Self-citation
PBMC of Multiple Sclerosis Patients Show Deregulation of OPA1 Processing Associated with Increased ROS and PHB2 Protein Levels
Rasmo, D. D., Ferretta, A., Russo, S., Ruggieri, M., Lasorella, P., Paolicelli, D., Trojano, M., & Signorile, A. (2020) · Biomedicines · doi:10.3390/biomedicines8040085 · Cited by 35
Antigen-Specific Treatment Modalities in MS: The Past, the Present, and the Future
Derdelinckx, J., Cras, P. P., Berneman, Z. N., & Cools, N. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.624685 · Cited by 35
Baricitinib Ameliorates Experimental Autoimmune Encephalomyelitis by Modulating the Janus Kinase/Signal Transducer and Activator of Transcription Signaling Pathway
Dang, C., Lu, Y., Chen, X., & Li, Q. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.650708 · Cited by 35
Antiplatelet drugs: Potential therapeutic options for the management of neurodegenerative diseases
Beura, S. K., Dhapola, R., Panigrahi, A. R., Yadav, P., Kumar, R., HariKrishnaReddy, D., & Singh, S. K. (2023) · Medicinal Research Reviews · doi:10.1002/med.21965 · Cited by 37
Solution NMR structure of an immunodominant epitope of myelin basic protein
Farès, C., Libich, D. S., & Harauz, G. (2006) · FEBS Journal · doi:10.1111/j.1742-4658.2005.05093.x · Cited by 35
Downregulation of IL-17 and IFN-γ in the optic nerve by β-elemene in experimental autoimmune encephalomyelitis
Zhang, R., Tian, A., Shi, X., Yu, H., & Chen, L. (2010) · International Immunopharmacology · doi:10.1016/j.intimp.2010.04.003 · Cited by 35
Neuroprotective effects of a polyphenolic white grape juice extract in a mouse model of experimental autoimmune encephalomyelitis
Giacoppo, S., Galuppo, M., Lombardo, G. E., Ulaszewska, M., Mattivi, F., Bramanti, P., Mazzon, E., & Navarra, M. (2015) · Fitoterapia · doi:10.1016/j.fitote.2015.04.003 · Cited by 35
A novel calpain inhibitor for the treatment of acute experimental autoimmune encephalomyelitis
Hassen, G. W., Feliberti, J. P., Kesner, L., Stracher, A., & Mokhtarian, F. (2006) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.08.005 · Cited by 35
The TLR7 agonist, imiquimod, increases IFN-β production and reduces the severity of experimental autoimmune encephalomyelitis
O’Brien, K., Fitzgerald, D. C., Rostami, A. M., & Gran, B. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.01.006 · Cited by 36
Selective Induction of cAMP Phosphodiesterase PDE4B2 Expression in Experimental Autoimmune Encephalomyelitis
Reyes-Irisarri, E., Sánchez, A., García-Merino, J. A., & Mengod, G. (2007) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181567c31 · Cited by 35
Roles of the kallikrein/kinin system in the adaptive immune system
Schulze‐Topphoff, U., Prat, A., Bäder, M., Zipp, F., & Aktaş, O. (2007) · International Immunopharmacology · doi:10.1016/j.intimp.2007.08.001 · Cited by 35
Effect of Estrogen on Th1, Th2 and Th17 Cytokines Production by Proteolipid Protein and PHA Activated Peripheral Blood Mononuclear Cells Isolated from Multiple Sclerosis Patients
Javadian, A., Salehi, E., Bidad, K., Sahraian, M. A., & Izad, M. H. (2014) · Archives of Medical Research · doi:10.1016/j.arcmed.2014.01.002 · Cited by 35
Gray Matter Hypoxia in the Brain of the Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis
Johnson, T. W., Wu, Y., Nathoo, N., Rogers, J. A., Yong, V. W., & Dunn, J. F. (2016) · PLoS ONE · doi:10.1371/journal.pone.0167196 · Cited by 40
Role of B Cells in Pathogenesis of Multiple Sclerosis
Nikbin, B., Bonab, M. M., Khosravi, F., & Talebian, F. (2007) · International review of neurobiology · doi:10.1016/s0074-7742(07)79002-5 · Cited by 35
The potential role of T cell migration and chemotaxis as targets of glucocorticoids in multiple sclerosis and experimental autoimmune encephalomyelitis
Fischer, H. J., Schweingruber, N., Lühder, F., & Reichardt, H. M. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.04.001 · Cited by 34
Engineering chimeric autoantibody receptor T cells for targeted B cell depletion in multiple sclerosis model: An in-vitro study
Sahlolbei, M., Azangou‐Khyavy, M., Khanali, J., Khorsand, B., Shiralipour, A., Ahmadbeigi, N., Madjd, Z., Ghanbarian, H., Ardjmand, A., Hashemi, S. M., et al. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e19763 · Cited by 34
Therapeutic potential of anti-CD137 (4-1BB) monoclonal antibodies
Vinay, D. S., & Kwon, B. S. (2015) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2016.1091448 · Cited by 34
The cerebrospinal fluid cytokine signature of multiple sclerosis: A homogenous response that does not conform to the Th1/Th2/Th17 convention
Burman, J., Svensson, E., Fransson, M. E., Loskog, A., Zetterberg, H., Raininko, R., Svenningsson, A., Fagius, J., & Mangsbo, S. M. (2014) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2014.10.005 · Cited by 34
Immune regulatory and neuroprotective properties of preimplantation factor: From newborn to adult
Barnea, E. R., Almogi‐Hazan, O., Or, R., Mueller, M., Ria, F., Weiss, L., & Paidas, M. J. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.10.008 · Cited by 34

Authors: Sospedra, M., & Martin, R.
Affiliations: National Institutes of Health (US)
Cellular Immunology Section, Neuroimmunology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland 20892-1400;
ORCID: Sospedra, Mireia
Venue: Annual Review of Immunology
Publisher: Annual Reviews
Published: 2005-04-01
Volume: 23
Issue: 1
Pages: 683-747
ISSN: 0732-0582 (ISSN-L)
1545-3278
DOI: 10.1146/annurev.immunol.23.021704.115707
OpenAlex: W2113291839
Cited by: 2,149
References: 362
Citations by year: 2026: 27 · 2025: 43 · 2024: 62 · 2023: 64 · 2022: 69 · 2021: 72 · 2020: 78 · 2019: 84 · 2018: 71 · 2017: 110 · 2016: 107 · 2015: 149 · 2014: 133 · 2013: 144 · 2012: 120
FWCI: 19.06
Type: journal article
Language: en
Open access: closed
Locations: Annual Review of Immunology (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
Keywords: multiple sclerosis, autoimmunity, CD4+ T cells, Th1 cells, Th2 cells, regulatory T cells, natural killer cells, CD8+ T cells, complement system, autoantibodies, innate immunity, viral triggers, genetic susceptibility, relapsing-remitting disease, chronic progressive disease, central nervous system, neuroimmune interactions
MeSH terms: Autoantibodies, Autoantigens, Central Nervous System, HLA Antigens, Humans, Immunity, Innate, Immunogenetics, Infections, Multiple Sclerosis, Myelin Proteins, T-Lymphocyte Subsets, Cytokines, Models, Immunological, Molecular Mimicry, Chemokines, Genomics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

IMMUNOLOGY OF MULTIPLE SCLEROSIS

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks